Aortic stenosis and ACE inhibitors

Comment

H Rimington et al. Lancet. 1998.

. 1998 Sep 5;352(9130):820-1.

doi: 10.1016/S0140-6736(05)60717-9.

No abstract available

Comment in

Aortic stenosis and ACE inhibitors.
Cox NL, Abdul-Hamid AR, Mulley GP. Cox NL, et al. Lancet. 1998 Oct 24;352(9137):1392. doi: 10.1016/s0140-6736(05)60791-x. Lancet. 1998. PMID: 9802306 No abstract available.

Why deny ACE inhibitors to patients with aortic stenosis?
Cox NL, Abdul-Hamid AR, Mulley GP. Cox NL, et al. Lancet. 1998 Jul 11;352(9122):111-2. doi: 10.1016/S0140-6736(98)85016-2. Lancet. 1998. PMID: 9672278 Review. No abstract available.

Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers After Transcatheter Aortic Valve Replacement: A Meta-Analysis.
Bhat V, Kumar A, Kalra A. Bhat V, et al. JACC Adv. 2024 Apr 6;3(5):100927. doi: 10.1016/j.jacadv.2024.100927. eCollection 2024 May. JACC Adv. 2024. PMID: 38939627 Free PMC article.
Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
Chen S, Redfors B, Nazif T, Kirtane A, Crowley A, Ben-Yehuda O, Kapadia S, Finn MT, Goel S, Lindman BR, Alu MC, Chau KH, Thourani VH, Vahl TP, Douglas PS, Kodali SK, Leon MB. Chen S, et al. Eur Heart J. 2020 Feb 21;41(8):943-954. doi: 10.1093/eurheartj/ehz769. Eur Heart J. 2020. PMID: 31711153 Free PMC article. Clinical Trial.
Renin-angiotensin system inhibitors reduce cardiovascular mortality in hypertensive patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry.
Basile C, Mancusi C, Franzone A, Avvedimento M, Bardi L, Angellotti D, Castiello DS, Mariani A, Manzo R, De Luca N, Cirillo P, De Simone G, Esposito G. Basile C, et al. Front Cardiovasc Med. 2023 Aug 24;10:1234368. doi: 10.3389/fcvm.2023.1234368. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37692038 Free PMC article.